Status:
RECRUITING
Liver Transplant CGM
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Liver Transplant
Post Transplant Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and li...
Detailed Description
Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospective...
Eligibility Criteria
Inclusion
- • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL
Exclusion
- having a planned discharge to a rehabilitation or nursing facility,
- a contraindication to sensor placement,
- if discharge is anticipated to be \>30 days post-transplant, or
- if recent transplant also included a kidney or pancreas transplant
Key Trial Info
Start Date :
October 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 5 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07216508
Start Date
October 13 2025
End Date
October 5 2027
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029